22 related articles for article (PubMed ID: 9504638)
1. Clinical evaluation of the bispecific antibody MDX-H210 (anti-Fc gamma RI x anti-HER-2/neu) in combination with granulocyte-colony-stimulating factor (filgrastim) for treatment of advanced breast cancer.
van Ojik HH; Repp R; Groenewegen G; Valerius T; van de Winkel JG
Cancer Immunol Immunother; 1997; 45(3-4):207-9. PubMed ID: 9435875
[No Abstract] [Full Text] [Related]
2. Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma.
Takemura S; Tomita N; Koharazawa H; Fujimaki K; Harano H; Hyo R; Yamazaki E; Hashimoto C; Miyazaki T; Ishigatsubo Y
Int J Hematol; 2012 Aug; 96(2):241-6. PubMed ID: 22684897
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression.
Danikas DD; Karakantza M; Theodorou GL; Sakellaropoulos GC; Gogos CA
Clin Exp Immunol; 2008 Oct; 154(1):87-97. PubMed ID: 18727624
[TBL] [Abstract][Full Text] [Related]
4. CD64 surface expression on neutrophils and monocytes is significantly up-regulated after stimulation with granulocyte colony-stimulating factor during CHOP chemotherapy for patients with non-Hodgkin's lymphoma.
Kakinoki Y; Kubota H; Yamamoto Y
Int J Hematol; 2004 Jan; 79(1):55-62. PubMed ID: 14979480
[TBL] [Abstract][Full Text] [Related]
5. Chimaeric Lym-1 monoclonal antibody-mediated cytolysis by neutrophils from G-CSF-treated patients: stimulation by GM-CSF and role of Fc gamma -receptors.
Ottonello L; Epstein AL; Mancini M; Tortolina G; Dapino P; Dallegri F
Br J Cancer; 2001 Aug; 85(3):463-9. PubMed ID: 11487281
[TBL] [Abstract][Full Text] [Related]
6. Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients.
Haicheur N; Escudier B; Dorval T; Negrier S; De Mulder PH; Dupuy JM; Novick D; Guillot T; Wolf S; Pouillart P; Fridman WH; Tartour E
Clin Exp Immunol; 2000 Jan; 119(1):28-37. PubMed ID: 10606961
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy.
Valerius T; Repp R; de Wit TP; Berthold S; Platzer E; Kalden JR; Gramatzki M; van de Winkel JG
Blood; 1993 Aug; 82(3):931-9. PubMed ID: 7687898
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
[TBL] [Abstract][Full Text] [Related]
9. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells.
Kerst JM; de Haas M; van der Schoot CE; Slaper-Cortenbach IC; Kleijer M; von dem Borne AE; van Oers RH
Blood; 1993 Dec; 82(11):3265-72. PubMed ID: 7694676
[TBL] [Abstract][Full Text] [Related]
10. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).
Repp R; Valerius T; Wieland G; Becker W; Steininger H; Deo Y; Helm G; Gramatzki M; Van de Winkel JG; Lang N
J Hematother; 1995 Oct; 4(5):415-21. PubMed ID: 8581378
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.
Stockmeyer B; Valerius T; Repp R; Heijnen IA; Bühring HJ; Deo YM; Kalden JR; Gramatzki M; van de Winkel JG
Cancer Res; 1997 Feb; 57(4):696-701. PubMed ID: 9044847
[TBL] [Abstract][Full Text] [Related]
12. In vivo induction of functional Fc gammaRI (CD64) on neutrophils and modulation of blood cytokine mRNA levels in cancer patients treated with G-CSF (rMetHuG-CSF).
Michon JM; Gey A; Moutel S; Tartour E; Meresse V; Fridman W; Teillaud JL
Br J Haematol; 1998 Mar; 100(3):550-6. PubMed ID: 9504638
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
